TY - JOUR AU - Blach, S. AU - Zeuzem, S. AU - Manns, M. AU - Altraif, I. AU - Duberg, A. -. S. AU - Muljono, D. H. AU - Waked, I. AU - Alavian, S. M. AU - Lee, M. -. H. AU - Negro, F. PY - 2017 DA - 2017// TI - Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study JO - Lancet Gastroenterol Hepatol VL - 2 UR - https://doi.org/10.1016/S2468-1253(16)30181-9 DO - 10.1016/S2468-1253(16)30181-9 ID - Blach2017 ER - TY - JOUR AU - Shepard, C. W. AU - Finelli, L. AU - Alter, M. J. PY - 2005 DA - 2005// TI - Global epidemiology of hepatitis C virus infection JO - Lancet Infect Dis VL - 5 UR - https://doi.org/10.1016/S1473-3099(05)70216-4 DO - 10.1016/S1473-3099(05)70216-4 ID - Shepard2005 ER - TY - JOUR AU - Hajarizadeh, B. AU - Grebely, J. AU - Dore, G. J. PY - 2013 DA - 2013// TI - Epidemiology and natural history of HCV infection JO - Nat Rev Gastroenterol Hepatol VL - 10 UR - https://doi.org/10.1038/nrgastro.2013.107 DO - 10.1038/nrgastro.2013.107 ID - Hajarizadeh2013 ER - TY - JOUR AU - Larney, S. AU - Kopinski, H. AU - Beckwith, C. G. AU - Zaller, N. D. AU - Jarlais, D. D. AU - Hagan, H. AU - Rich, J. D. AU - van den Bergh, B. J. AU - Degenhardt, L. PY - 2013 DA - 2013// TI - Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis JO - Hepatology VL - 58 UR - https://doi.org/10.1002/hep.26387 DO - 10.1002/hep.26387 ID - Larney2013 ER - TY - JOUR AU - Dolan, K. AU - Wirtz, A. L. AU - Moazen, B. AU - Ndeffo-mbah, M. AU - Galvani, A. AU - Kinner, S. A. AU - Courtney, R. AU - McKee, M. AU - Amon, J. J. AU - Maher, L. PY - 2016 DA - 2016// TI - Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30466-4 DO - 10.1016/S0140-6736(16)30466-4 ID - Dolan2016 ER - TY - STD TI - Butler T, Simpson M. National Prison Entrants’ Blood-borne Virus Survey report 2004, 2007, 2010, 2013, and 2016. Sydney: The Kirby Institute (UNSW Sydney); 2017. ID - ref6 ER - TY - JOUR AU - Manns, M. P. AU - Wedemeyer, H. AU - Cornberg, M. PY - 2006 DA - 2006// TI - Treating viral hepatitis C: efficacy, side effects, and complications JO - Gut VL - 55 UR - https://doi.org/10.1136/gut.2005.076646 DO - 10.1136/gut.2005.076646 ID - Manns2006 ER - TY - JOUR AU - Pawlotsky, J. -. M. PY - 2014 DA - 2014// TI - New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development JO - Semin Liver Dis VL - 34 UR - https://doi.org/10.1055/s-0034-1371007 DO - 10.1055/s-0034-1371007 ID - Pawlotsky2014 ER - TY - JOUR AU - Dore, G. J. AU - Feld, J. J. PY - 2015 DA - 2015// TI - Hepatitis C virus therapeutic development: in pursuit of “Perfectovir” JO - Clin Infect Dis VL - 60 UR - https://doi.org/10.1093/cid/civ197 DO - 10.1093/cid/civ197 ID - Dore2015 ER - TY - JOUR AU - Chung, R. T. AU - Baumert, T. F. PY - 2014 DA - 2014// TI - Curing chronic hepatitis C––the arc of a medical triumph JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMp1400986 DO - 10.1056/NEJMp1400986 ID - Chung2014 ER - TY - JOUR AU - Grebely, J. AU - Matthews, G. V. AU - Lloyd, A. R. AU - Dore, G. J. PY - 2013 DA - 2013// TI - Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit377 DO - 10.1093/cid/cit377 ID - Grebely2013 ER - TY - JOUR AU - Hickman, M. AU - De Angelis, D. AU - Vickerman, P. AU - Hutchinson, S. AU - Martin, N. K. PY - 2015 DA - 2015// TI - Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence JO - Curr Opin Infect Dis VL - 28 UR - https://doi.org/10.1097/QCO.0000000000000216 DO - 10.1097/QCO.0000000000000216 ID - Hickman2015 ER - TY - JOUR AU - Platt, L. AU - Minozzi, S. AU - Reed, J. AU - Vickerman, P. AU - Hagan, H. AU - French, C. AU - Jordan, A. AU - Degenhardt, L. AU - Hope, V. AU - Hutchinson, S. PY - 2017 DA - 2017// TI - Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs JO - Cochrane Database Syst Rev VL - 9 ID - Platt2017 ER - TY - JOUR AU - Hajarizadeh, B. AU - Grebely, J. AU - Martinello, M. AU - Matthews, G. V. AU - Lloyd, A. R. AU - Dore, G. J. PY - 2016 DA - 2016// TI - Hepatitis C treatment as prevention: evidence, feasibility, and challenges JO - Lancet Gastroenterol Hepatol VL - 1 UR - https://doi.org/10.1016/S2468-1253(16)30075-9 DO - 10.1016/S2468-1253(16)30075-9 ID - Hajarizadeh2016 ER - TY - BOOK PY - 2015 DA - 2015// TI - Turnbull govt invests over $1B to cure hep C PB - The Hon Sussan Ley MP, Minister for Health CY - Canberra ID - ref15 ER - TY - JOUR AU - Barua, S. AU - Greenwald, R. AU - Grebely, J. AU - Dore, G. J. AU - Swan, T. AU - Taylor, L. E. PY - 2015 DA - 2015// TI - Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis c virus infection in the United States JO - Ann Intern Med VL - 163 UR - https://doi.org/10.7326/M15-0406 DO - 10.7326/M15-0406 ID - Barua2015 ER - TY - JOUR AU - Marshall, A. D. AU - Saeed, S. AU - Barrett, L. AU - Cooper, C. L. AU - Treloar, C. AU - Bruneau, J. AU - Feld, J. J. AU - Gallagher, L. AU - Klein, M. B. AU - Krajden, M. PY - 2016 DA - 2016// TI - Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study JO - CMAJ Open VL - 4 UR - https://doi.org/10.9778/cmajo.20160008 DO - 10.9778/cmajo.20160008 ID - Marshall2016 ER - TY - JOUR AU - Marshall, A. D. AU - Cunningham, E. B. AU - Nielsen, S. AU - Aghemo, A. AU - Alho, H. AU - Backmund, M. AU - Bruggmann, P. AU - Dalgard, O. AU - Seguin-Devaux, C. AU - Flisiak, R. PY - 2018 DA - 2018// TI - Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe JO - Lancet Gastroenterol Hepatol VL - 3 UR - https://doi.org/10.1016/S2468-1253(17)30284-4 DO - 10.1016/S2468-1253(17)30284-4 ID - Marshall2018 ER - TY - JOUR AU - Martin, N. K. AU - Vickerman, P. AU - Dore, G. J. AU - Hickman, M. PY - 2015 DA - 2015// TI - The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention JO - Curr Opin HIV AIDS VL - 10 UR - https://doi.org/10.1097/COH.0000000000000179 DO - 10.1097/COH.0000000000000179 ID - Martin2015 ER - TY - JOUR AU - Mina, M. M. AU - Herawati, L. AU - Butler, T. AU - Lloyd, A. PY - 2016 DA - 2016// TI - Hepatitis C in Australian prisons: a national needs assessment JO - Int J Prison Health VL - 12 UR - https://doi.org/10.1108/IJPH-08-2015-0025 DO - 10.1108/IJPH-08-2015-0025 ID - Mina2016 ER - TY - CHAP AU - Milat, A. AU - Newson, R. AU - King, L. PY - 2014 DA - 2014// TI - Increasing the scale of population health interventions: a guide BT - Evidence and Evaluation Guidance Series, Population and Public Health Division PB - Sydney CY - NSW Ministry of Health ID - Milat2014 ER - TY - BOOK PY - 2014 DA - 2014// TI - Prisoner health services in Australia. 14 Aug 2014 edition PB - Canberra CY - Welfare ID - ref22 ER - TY - BOOK AU - Wallace, J. AU - Pitts, M. AU - McNally, S. AU - Malkin, I. AU - Temple-Smith, M. AU - Smith, A. AU - Levy, M. PY - 2010 DA - 2010// TI - Regulating hepatitis C: rights and duties, preventing hepatitis C transmission in Australian adult correctional settings PB - Australian Research Centre in Sex, Health and Society, La Trobe University CY - Melbourne ID - Wallace2010 ER - TY - JOUR AU - Ritter, A. AU - Berends, L. PY - 2016 DA - 2016// TI - Twenty years of (non)reform in Victorian alcohol and other drug treatment policy JO - Drug Alcohol Rev VL - 35 UR - https://doi.org/10.1111/dar.12374 DO - 10.1111/dar.12374 ID - Ritter2016 ER - TY - JOUR AU - Hyshka, E. AU - Anderson-Baron, J. AU - Karekezi, K. AU - Belle-Isle, L. AU - Elliott, R. AU - Pauly, B. AU - Strike, C. AU - Asbridge, M. AU - Dell, C. AU - McBride, K. PY - 2017 DA - 2017// TI - Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks JO - Harm Reduct J VL - 14 UR - https://doi.org/10.1186/s12954-017-0177-7 DO - 10.1186/s12954-017-0177-7 ID - Hyshka2017 ER - TY - STD TI - Victoria Health and Human Services. Victorian hepatitis C strategy 2016–2020. Melbourne: Victoria State Government; 2016. ID - ref26 ER - TY - STD TI - Queensland Health. Queensland alcohol and other drugs action plan 2015–2017: thriving communities. Brisbane: Queensland Government; 2015. ID - ref27 ER - TY - STD TI - South Australia Department of Health and Ageing. South Australian Hepatitis C Implementation and Evaluation Plan 2015–2016. Adelaide: Government of South Australia; 2015. ID - ref28 ER - TY - STD TI - South Australia Department for Correctional Services and South Australia Department for Health and Ageing. South Australian Prisoner Blood Borne Virus Prevention Action Plan 2017–2020. Adelaide: Government of South Australia; 2017. ID - ref29 ER - TY - STD TI - Corrections Victoria. Corrections alcohol and drug strategy 2015. Melbourne: Victoria State Government; 2015. ID - ref30 ER - TY - STD TI - Western Australia Department of Health. Western Australia hepatitis C strategy 2015–2018. Perth: Government of Western Australia; 2015. ID - ref31 ER - TY - STD TI - Western Australia Department of Health. Hepatitis C virus model of care. Perth: Government of Western Australia; 2009. ID - ref32 ER - TY - STD TI - NSW Ministry of Health. NSW hepatitis C strategy 2014–2020. Sydney: NSW Ministry of Health; 2014. ID - ref33 ER - TY - STD TI - ACT Government. Strategic framework for the management of blood-borne viruses in the Alexander Maconochie Centre 2013–2017. Canberra: ACT Government; 2013. ID - ref34 ER - TY - STD TI - SA Prison Health Service. SA Prison Health Service Model of Care. Adelaide: Government of South Australia; 2016. ID - ref35 ER - TY - STD TI - ACT Health. ACT statement of priorities 2016–2020: hepatitis B, hepatitis C, HIV, and sexually transmissable infections. Canberra: ACT Government; 2016. ID - ref36 ER - TY - STD TI - ACT Government. Corrections management (infectious diseases) policy 2014 (no 1). Canberra: ACT Government; 2014. ID - ref37 ER - TY - STD TI - Victoria Office of the Correctional Services Commissioner. Identified drug user program: key policies and procedures. Melbourne: Victoria State Government; 2002. ID - ref38 ER - TY - JOUR AU - Spaulding, A. C. AU - Thomas, D. L. PY - 2012 DA - 2012// TI - Screening for HCV infection in jails JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.374 DO - 10.1001/jama.2012.374 ID - Spaulding2012 ER - TY - JOUR AU - Lloyd, A. R. AU - Clegg, J. AU - Lange, J. AU - Stevenson, A. AU - Post, J. J. AU - Lloyd, D. AU - Rudge, G. AU - Boonwaat, L. AU - Forrest, G. AU - Douglas, J. AU - Monkley, D. PY - 2013 DA - 2013// TI - Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis1202 DO - 10.1093/cid/cis1202 ID - Lloyd2013 ER - TY - JOUR AU - Stoové, M. AU - Treloar, C. J. AU - Maher, L. AU - Tyrrell, H. AU - Wallace, J. PY - 2015 DA - 2015// TI - Salvaging a prison needle and syringe program trial in Australia requires leadership and respect for evidence JO - Med J Aust VL - 203 UR - https://doi.org/10.5694/mja15.00523 DO - 10.5694/mja15.00523 ID - Stoové2015 ER - TY - JOUR AU - Hellard, M. AU - McBryde, E. AU - Sacks Davis, R. AU - Rolls, D. A. AU - Higgs, P. AU - Aitken, C. AU - Thompson, A. AU - Doyle, J. AU - Pattison, P. AU - Robins, G. PY - 2015 DA - 2015// TI - Hepatitis C transmission and treatment as prevention –: the role of the injecting network JO - Int J Drug Policy VL - 26 UR - https://doi.org/10.1016/j.drugpo.2015.05.006 DO - 10.1016/j.drugpo.2015.05.006 ID - Hellard2015 ER - TY - STD TI - Cunningham EB, Hajarizadeh B, Bretana NA, Amin J, Betz-Stablein B, Dore GJ, Luciani F, Teutsch S, Dolan K, Lloyd AR, et al. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005–2014: the HITS-p study. J Viral Hepat. 2017;24:733–41. ID - ref43 ER - TY - JOUR AU - Bretaña, N. AU - Boelen, L. AU - Bull, R. AU - Teutsch, S. AU - White, P. AU - Lloyd, A. AU - Luciani, F. PY - 2015 DA - 2015// TI - Transmission of hepatitis C virus among prisoners, Australia, 2005–2012 JO - Emerg Infect Dis VL - 21 UR - https://doi.org/10.3201/eid2105.141832 DO - 10.3201/eid2105.141832 ID - Bretaña2015 ER - TY - JOUR AU - Kamarulzaman, A. AU - Reid, S. E. AU - Schwitters, A. AU - Wiessing, L. AU - El-Bassel, N. AU - Dolan, K. AU - Moazen, B. AU - Wirtz, A. L. AU - Verster, A. AU - Altice, F. L. PY - 2016 DA - 2016// TI - Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30769-3 DO - 10.1016/S0140-6736(16)30769-3 ID - Kamarulzaman2016 ER - TY - STD TI - Dore GJ. Eliminating hepatitis C over the next decade. Sydney: UNSW Australia; 2016. ID - ref46 ER -